Company intelligence / Profile preview

Marpé Technologies

Tel Aviv (operation at Tel Aviv Sourasky Medical Center), Israel

Ownership: Private
Development stage: Other

Overview

Marpé Technologies has developed a high-resolution, technician-operated scanner for full-body screening to aid in the early detection of skin cancer, particularly melanoma. The system uses advanced optics, machine learning, and AI software to map and track moles, achieving a high rate of positive identification for suspicious lesions. Prototype devices are operational in Israeli hospitals, and the company has received FDA Breakthrough Device designation for its technology[1].

Therapeutic areas: Oncology
Modalities: DeviceAI/Software
Industry: Medical Imaging

Partnerships

Mayo Clinic (installation and clinical collaboration)[1]Technion (Israeli Institute of Technology; AI/software development)[1]Nortech Systems (commercial partnership for product development)[1]BIRD Foundation (Israel-U.S. Binational Industrial R&D Foundation; funding)[1]

Beyond the preview

Go deeper on Marpé Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marpé Technologies.

Explore the full profile